BioCentury
ARTICLE | Financial News

InventisBio raises $70M series C to advance early stage pipeline

March 12, 2019 6:40 PM UTC

InventisBio raised $70 million in a series C round led by Advantech Capital and CMBI, the Chinese biotech announced late Monday. Pudong Innotek and existing investors Lilly Asia Ventures and OrbiMed Asia also participated in the round, which InventisBio Inc. (Shanghai, China) said closed in January.

InventisBio has eight small molecules in preclinical to Phase II testing for various cancers, gout and non-alcoholic steatohepatitis (NASH), according to its website. ...

BCIQ Company Profiles

InventisBio Co. Ltd.